| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79f1153131b14a956fe4bc95108c1638 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-555 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04 |
| filingDate |
2002-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a6581494edee8b4da26ca52d98459c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c651bc8e7d0e43f3a3d2c652b024ee91 |
| publicationDate |
2003-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003104012-A1 |
| titleOfInvention |
Vaccines for the treatment of autoimmune disease |
| abstract |
The present invention provides pharmaceutical compositions comprising M. vaccae cells for treatment of autoimmune diseases such as diabetes, multiple sclerosis, rheumatoid arthritis, and scleroderma. The compositions may comprise either killed cells or delipidated and deglycolipidated cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016271257-A1 |
| priorityDate |
2001-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |